Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) has conducted a comprehensive review of Bayer shares. Here are the results found.
The private bank Berenberg has left the rating for Bayer at “Hold” with a price target of 34 euros. For investors in the chemical industry, 2024 is likely to be the year they had actually hoped for in 2023 – a year of volume recovery and improved profitability, analyst Sebastian Bray wrote in a study available on Wednesday. The last major cuts should have been made to profit expectations for 2023. He sees diversified companies in particular in a good starting position. At Bayer, investors were mainly waiting for the Investor Day on March 5th./tih/stk
Between price target and reality: Bayer shares in detail on the day of the analysis
Bayer shares were listed in green in XETRA trading at 2:05 p.m. and gained 0.2 percent to EUR 32.58. In this respect, the share still has an increase prospect of 4.36 percent compared to the analyst forecast. Recently, 864,660 Bayer shares changed hands. The paper has fallen by 3.1 percent since the beginning of 2024. Bayer is expected to present its upcoming financial results for Q4 2023 on March 5, 2024.
HAMBURG (dpa-AFX Analyzer) / editorial team finanzen.net
Publication of the original study: January 23, 2024 / 5:33 p.m. / GMT
First-time distribution of the original study: date not specified in study / time not specified in study / time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 Para. 1 WpHG, Art. 20 Regulation (EU) 596/2014 for the analyst firm mentioned can be found at http://web.dpa-afx.de/offenstellenpflicht/ disclosure_duty.html.
Selected leverage products on Bayer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Bayer
The leverage must be between 2 and 20
Advertising